These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Is radical prostatectomy the "gold standard" for localized prostate cancer? Mendenhall WM; Nichols RC; Henderson R; Mendenhall NP Am J Clin Oncol; 2010 Oct; 33(5):511-5. PubMed ID: 20010078 [TBL] [Abstract][Full Text] [Related]
7. [Quality of life in patients after radical prostatectomy]. Kamalov AA; Khomeriki GG; Efremov EA; Romikh VV; Egorov AA; Okhobotov DA Urologiia; 2005; (4):27-9. PubMed ID: 16158742 [TBL] [Abstract][Full Text] [Related]
8. A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. Ficarra V; Novara G; Fracalanza S; D'Elia C; Secco S; Iafrate M; Cavalleri S; Artibani W BJU Int; 2009 Aug; 104(4):534-9. PubMed ID: 19281468 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of radical retropubic prostatectomy: a report of 132 cases]. Huang YR; Wang YT; Xue W; Liu DM; Zhou LX Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):365-8. PubMed ID: 16638341 [TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 years. Ploussard G; de la Taille A; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; Salomon L BJU Int; 2011 Jan; 107(2):274-9. PubMed ID: 20575978 [TBL] [Abstract][Full Text] [Related]
11. Time course and predictors of symptoms after primary prostate cancer therapy. Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420 [TBL] [Abstract][Full Text] [Related]
13. [Long-term results of retropubic radical prostatectomy]. Petrov SB; Rakul SA; Galimov RD Vestn Khir Im I I Grek; 2010; 169(1):117-22. PubMed ID: 20387620 [TBL] [Abstract][Full Text] [Related]
14. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. Pardo Y; Guedea F; Aguiló F; Fernández P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Craven-Bratle J; Suárez JF; Boladeras A; Pont À; Ayala A; Sancho G; Martínez E; Alonso J; Ferrer M J Clin Oncol; 2010 Nov; 28(31):4687-96. PubMed ID: 20921463 [TBL] [Abstract][Full Text] [Related]
15. [Morbidity of radical prostatectomy for localized cancer of the prostate. Apropos of 100 cases]. Adjiman S; Zerbib M; Conquy S; Flam T; Peyret C; Martinache PR; Géraud M; Steg A; Debré B J Urol (Paris); 1992; 98(2):73-7. PubMed ID: 1431187 [TBL] [Abstract][Full Text] [Related]
16. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365 [TBL] [Abstract][Full Text] [Related]
17. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy. Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133 [TBL] [Abstract][Full Text] [Related]
18. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. Glickman L; Godoy G; Lepor H J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349 [TBL] [Abstract][Full Text] [Related]